| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/06/2005 | WO2004080402A3 Potassium salt of an hiv integrase inhibitor |
| 05/06/2005 | WO2004064736A3 Treatment of benign prostatic hyperplasia using energolytic agents |
| 05/06/2005 | WO2004064725A3 Oral compositions and methods for treatment of adverse effects or radiation |
| 05/06/2005 | WO2004060282A3 Uses of the snorf207 receptor |
| 05/06/2005 | WO2004052303A3 A method for creating nuclear receptor activity modulating pharmaceuticals |
| 05/06/2005 | WO2004047727A3 Compositions and methods for diagnosing and treating mood disorders |
| 05/06/2005 | WO2004032823A8 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
| 05/06/2005 | CA2585024A1 Macromer-melt formulations |
| 05/06/2005 | CA2543319A1 Methods of treating leukemia with suberoylanilide hydroxamic acid |
| 05/06/2005 | CA2543312A1 Methods and compositions comprising thalidomide for treatment of fibromyalgia |
| 05/06/2005 | CA2542963A1 Inhibitors of cathepsin s |
| 05/06/2005 | CA2542661A1 Methods and compositions for treating cancer |
| 05/06/2005 | CA2541989A1 P70s6 kinase modulators and method of use |
| 05/06/2005 | CA2536535A1 Compounds and compositions as protein kinase inhibitors |
| 05/06/2005 | CA2526804A1 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| 05/05/2005 | US20050096485 Thyronamine derivatives and analogs and methods of use thereof |
| 05/05/2005 | US20050096375 through augmentation of glutamatergic neurotransmission; Central nervous system disorders, cognitive disorders, schizophrenia, dementia; 3-aza-bicyclo[3.1.0]hexanes; Thiophene-2-carboxylic acid (3-cyclohexylmethyl-3-aza-bicyclo[3.1.0]hex-6-ylmethyl)-(3-fluoro-4-morpholin-4-yl-phenyl)-amide |
| 05/05/2005 | US20050096351 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/05/2005 | US20050096333 Quinazoline derivatives as medicaments |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/05/2005 | US20050096281 Administering cognition activators to improve memory and treat cognitive decline or senility by administering extracts of plants |
| 05/05/2005 | US20050096259 Neutrophil activation by immune response modifier compounds |
| 05/05/2005 | US20050095593 T cell regulatory genes associated with immune disease |
| 05/05/2005 | US20050095281 Vesicle of lipid or phospholipid; and monoglyceride, fatty acid, and/or lysophospholipid active agent; preventing infection from vesicular stomatitis, visna, herpes, myxo-, lymphadenopathy associated, and/or human T-cell leukemia virus; and gonorrhea, chlamdia; time-release agents |
| 05/05/2005 | US20050095278 Topical drug delivery using transdermal patch; ointments, creams; oral administration |
| 05/05/2005 | US20050095263 Allowing full spoon filling for accurate pharmaceutical dosage; storage stability |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/05/2005 | US20050095229 Comprises conduit connected to blood pool, cell culture for producing analyte (insulin, glucagons, and/or somatostatin), and concentration controller (integrated circuit) |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527787A1 Immediate release tablet |
| 05/04/2005 | EP1527775A1 Controlled release formulation containing tramadol |
| 05/04/2005 | EP1401466B1 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 05/04/2005 | EP1169029B1 Use of sibutramine or its derivative for the treatment of sleep disorders |
| 05/04/2005 | CN1612878A Synthesis and purification of valacyclovir |
| 05/04/2005 | CN1199631C Epillatory compositions |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887881 For use as antiarrhythmic drug |
| 05/03/2005 | US6887855 Crystal structure; for treatment of myelodysplastic syndromes |
| 05/03/2005 | US6887673 Containing light chain and a heavy chain peptide; anticarcinogenic agent |
| 05/03/2005 | US6887500 Compositions for lowering blood pressure |
| 05/03/2005 | CA2325045C Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 04/28/2005 | WO2005037235A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/28/2005 | WO2005037233A2 Listeria-based epha2 vaccines |
| 04/28/2005 | WO2005037232A2 Methods and compositions for modulating adipocyte function |
| 04/28/2005 | WO2005037231A2 Methods of detecting and treating facioscapulohumeral muscular dystrophy |
| 04/28/2005 | WO2005037230A2 Compositions and methods for treating heart failure |
| 04/28/2005 | WO2005037229A2 Methods and compositions for modulating gamete adhesion |
| 04/28/2005 | WO2005037228A2 Halogen phosphonate monoesters |
| 04/28/2005 | WO2005037227A2 Selective cox-2 inhibitors |
| 04/28/2005 | WO2005037226A2 Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders |
| 04/28/2005 | WO2005037225A2 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 04/28/2005 | WO2005037224A2 Muscarinic acetylcholine receptor antagonists |
| 04/28/2005 | WO2005037223A2 Methods and compositions for immunomodulation |
| 04/28/2005 | WO2005037222A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/28/2005 | WO2005037221A2 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 04/28/2005 | WO2005037219A2 Disinfecting teat care compositions |
| 04/28/2005 | WO2005037218A2 Lentiviral vector delivery of il-21 for treatment of cancer |
| 04/28/2005 | WO2005037217A2 Lentiviral vector delivery of msp36 for treatment of cancer |
| 04/28/2005 | WO2005037216A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 04/28/2005 | WO2005037215A2 Compositions and methods for enhancing cognitive function and synaptic plasticity |
| 04/28/2005 | WO2005037214A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/28/2005 | WO2005037213A2 Antiinflammatory inhibitors of respiratory burst in adherent neutrophils |
| 04/28/2005 | WO2005037212A2 Treatment of chemical dependency with substantially nonaddicting normorphine and norcodeine derivatives |
| 04/28/2005 | WO2005037211A2 Methods and compositions for the treatment of neurological disease |
| 04/28/2005 | WO2005037210A2 Photocleavable isotope-coded affinity tags |
| 04/28/2005 | WO2005037209A2 A method for the separation anti-amyloid beta antibody with amyloid beta peptide |
| 04/28/2005 | WO2005037208A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005037206A2 Anti-cancer compounds and methods of use thereof |
| 04/28/2005 | WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof |
| 04/28/2005 | WO2005037204A2 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 04/28/2005 | WO2005037201A2 Treating bone-related disorders with selective androgen receptor modulators |
| 04/28/2005 | WO2005037200A2 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 04/28/2005 | WO2005037198A2 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors |
| 04/28/2005 | WO2005037197A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 04/28/2005 | WO2005037196A2 Substituted 2-arylmethylene-n-aryl-n'-aryl-malonamides and analogs as activators of caspases and inducers of apoptosis |
| 04/28/2005 | WO2005037195A2 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 04/28/2005 | WO2005037194A2 Collagen interactions with prostate cancer cells |
| 04/28/2005 | WO2005037193A2 Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury |
| 04/28/2005 | WO2005037191A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 04/28/2005 | WO2005037190A2 Multiplex vaccines |
| 04/28/2005 | WO2005037188A2 Therapeutic agent for periodontal disease |
| 04/28/2005 | WO2005037187A2 High affinity ligands for influenza virus and methods for their production |
| 04/28/2005 | WO2005020920A3 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 04/28/2005 | WO2005020895A3 Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
| 04/28/2005 | WO2005016284A3 Gloves containing dry powdered aloe and method of manufacturing |
| 04/28/2005 | WO2005013910A3 Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2005011591A3 Method for the treatment of sleep disorders |
| 04/28/2005 | WO2005011581A3 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/28/2005 | WO2005009351A3 Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics |
| 04/28/2005 | WO2005007115A3 Pharmaceutical composition for inhibiting acid secretion |
| 04/28/2005 | WO2005007091A3 Histone deacetylase inhibitors and methods of use thereof |
| 04/28/2005 | WO2005002524A3 COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα |
| 04/28/2005 | WO2005002522A3 Compositions and methods for treating tissue ischemia |
| 04/28/2005 | WO2005000243A3 The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butryric acid |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004110351A3 Heterocyclic compounds for treating hepatitis c virus |
| 04/28/2005 | WO2004098531A3 Increased transduction using abc transporter substrates and/or inhibitors |